<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34163217</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7074</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>International journal of general medicine</Title><ISOAbbreviation>Int J Gen Med</ISOAbbreviation></Journal><ArticleTitle>The Conundrum of 'Long-COVID-19': A Narrative Review.</ArticleTitle><Pagination><StartPage>2491</StartPage><EndPage>2506</EndPage><MedlinePgn>2491-2506</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IJGM.S316708</ELocationID><Abstract><AbstractText>COVID-19 is an ongoing pandemic with many challenges that are now extending to its intriguing long-term sequel. 'Long-COVID-19' is a term given to the lingering or protracted illness that patients of COVID-19 continue to experience even in their post-recovery phase. It is also being called 'post-acute COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain fog, anosmia, and dysgeusia are common symptoms seen in Long-COVID-19, but more varied and debilitating injuries involving pulmonary, cardiovascular, cutaneous, musculoskeletal and neuropsychiatric systems are also being reported. With the data on Long-COVID-19 still emerging, the present review aims to highlight its epidemiology, protean clinical manifestations, risk predictors, and management strategies. With the re-emergence of new waves of SARS-CoV-2 infection, Long-COVID-19 is expected to produce another public health crisis on the heels of current pandemic. Thus, it becomes imperative to emphasize this condition and disseminate its awareness to medical professionals, patients, the public, and policymakers alike to prepare and augment health care facilities for continued surveillance of these patients. Further research comprising cataloging of symptoms, longer-ranging observational studies, and clinical trials are necessary to evaluate long-term consequences of COVID-19, and it warrants setting-up of dedicated, post-COVID care, multi-disciplinary clinics, and rehabilitation centers.</AbstractText><CopyrightInformation>&#xa9; 2021 Garg et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Mandeep</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4714-6299</Identifier><AffiliationInfo><Affiliation>Department of Radiodiagnosis &amp; Imaging, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maralakunte</LastName><ForeName>Muniraju</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3708-3503</Identifier><AffiliationInfo><Affiliation>Department of Radiodiagnosis &amp; Imaging, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Suruchi</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5077-4192</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Aura Skin Institute, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhooria</LastName><ForeName>Sahajal</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sehgal</LastName><ForeName>Inderpaul</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhalla</LastName><ForeName>Ashu Seith</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Radiodiagnosis, AIIMS, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijayvergiya</LastName><ForeName>Rajesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grover</LastName><ForeName>Sandeep</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatia</LastName><ForeName>Vikas</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Radiodiagnosis &amp; Imaging, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagia</LastName><ForeName>Priya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Imaging &amp; Endovascular Interventions, AIIMS, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhalla</LastName><ForeName>Ashish</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suri</LastName><ForeName>Vikas</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goyal</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Ritesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puri</LastName><ForeName>Goverdhan Dutt</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandhu</LastName><ForeName>Manavjit Singh</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Radiodiagnosis &amp; Imaging, PGIMER, Chandigarh, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Int J Gen Med</MedlineTA><NlmUniqueID>101515487</NlmUniqueID><ISSNLinking>1178-7074</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Long-COVID-19</Keyword><Keyword MajorTopicYN="N">chronic COVID</Keyword><Keyword MajorTopicYN="N">ongoing symptomatic COVID-19</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34163217</ArticleId><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="doi">10.2147/IJGM.S316708</ArticleId><ArticleId IdType="pii">316708</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Garg S, Garg M, Prabhakar N, Malhotra P, Agarwal R. Unraveling the mystery of Covid-19 cytokine storm: from skin to organ systems. Dermatol Ther. 2020;33(6):1385&#x2013;1389. doi:10.1111/dth.13859</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dth.13859</ArticleId><ArticleId IdType="pmc">PMC7323083</ArticleId><ArticleId IdType="pubmed">32559324</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017&#x2013;1032. doi:10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO [homepage on the internet]. Coronavirus disease (COVID-19). [updated
November
10, 2020]. Available from: https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19/. Accessed December14, 2020.</Citation></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi:10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: what do we know about &#x201c;long covid&#x201d;? BMJ. 2020;370:m2815. doi:10.1136/bmj.m2815</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi:10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med. 2021;268:113426. doi:10.1016/j.socscimed.2020.113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Worldometer [Homepage on internet]. Coronavirus update. Available from: https://www.worldometers.info/coronavirus/. Accessed May15, 2021.</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv [Preprint]. 2021. doi:10.1101/2021.01.27.21250617</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Barman MP, Rahman T, Bora K, Borgohain C. COVID-19 pandemic and its recovery time of patients in India: a pilot study. Diabetes Metab Syndr. 2020;14(5):1205&#x2013;1211. doi:10.1016/j.dsx.2020.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.07.004</ArticleId><ArticleId IdType="pmc">PMC7343664</ArticleId><ArticleId IdType="pubmed">32673841</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Alcoba G, et al. COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings. Ann Intern Med. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi:10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. The prevalence of long COVID symptoms and COVID-19 complications. [updated
December
16, 2020]. Available from: https://www.ons.gov.uk/. Accessed February2, 2021.</Citation></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3&#x2005;months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;2020. doi:10.1183/23120541.00542-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4&#x2013;e6. doi:10.1016/j.jinf.2020.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89&#x2013;95. doi:10.1016/j.cmi.2020.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J; COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391. doi:10.1136/bmjopen-2020-048391</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258&#x2013;263. doi:10.1016/j.cmi.2020.09.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing Long COVID in an international cohort: 7 Months of symptoms and their impact. medRxiv [Preprint]. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez Castro J. Post-COVID-19 syndrome (PC19S): chronic reactive endotheliitis and disseminated vascular disease. Acta Med Port. 2020;33(12):859. doi:10.20344/amp.14612</Citation><ArticleIdList><ArticleId IdType="doi">10.20344/amp.14612</ArticleId><ArticleId IdType="pubmed">33496258</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2013;332. doi:10.1016/j.ijid.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Ciccarelli M, Cecconi M, et al. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging. 2020;30:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Arag&#xe3;o MFVV, Leal MC, Cartaxo Filho OQ, Fonseca TM, Valen&#xe7;a MM. Anosmia in COVID-19 associated with injury to the olfactory bulbs evident on MRI. AJNR Am J Neuroradiol. 2020;41:1703&#x2013;1706. doi:10.3174/ajnr.A6675</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6675</ArticleId><ArticleId IdType="pmc">PMC7583088</ArticleId><ArticleId IdType="pubmed">32586960</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss SB, Lantos JE, Heier LA, Shatzkes DR, Phillips CD. Olfactory bulb signal abnormality in patients with COVID-19 who present with neurologic symptoms. AJNR Am J Neuroradiol. 2020;41:1882&#x2013;1887. doi:10.3174/ajnr.A6751</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6751</ArticleId><ArticleId IdType="pmc">PMC7661060</ArticleId><ArticleId IdType="pubmed">32855190</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncati L, Ligabue G, Fabbiani L, et al. Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol. 2020;217:108487. doi:10.1016/j.clim.2020.108487</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108487</ArticleId><ArticleId IdType="pmc">PMC7256503</ArticleId><ArticleId IdType="pubmed">32479986</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155&#x2013;162. doi:10.1097/BOR.0000000000000776</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000776</ArticleId><ArticleId IdType="pmc">PMC7880581</ArticleId><ArticleId IdType="pubmed">33332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussein HM, Rahal EA. The role of viral infections in the development of autoimmune diseases. Crit Rev Microbiol. 2019;45:394&#x2013;412. doi:10.1080/1040841X.2019.1614904</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1040841X.2019.1614904</ArticleId><ArticleId IdType="pubmed">31145640</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev. 2006;19:80&#x2013;94. doi:10.1128/CMR.19.1.80-94.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.19.1.80-94.2006</ArticleId><ArticleId IdType="pmc">PMC1360274</ArticleId><ArticleId IdType="pubmed">16418524</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M, Tincani A, Andreoli L, et al. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19:102597. doi:10.1016/j.autrev.2020.102597</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Han T, Chen J, et al. Clinical and autoimmune characteristics of severe and critical cases of COVID-19. Clin Transl Sci. 2020;13:1077&#x2013;1086. doi:10.1111/cts.12805</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12805</ArticleId><ArticleId IdType="pmc">PMC7264560</ArticleId><ArticleId IdType="pubmed">32315487</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzog EL, Mathur A, Tager AM, et al. Interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct? Arthritis Rheumatol. 2014;66:1967&#x2013;1978. doi:10.1002/art.38702</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38702</ArticleId><ArticleId IdType="pmc">PMC4340472</ArticleId><ArticleId IdType="pubmed">24838199</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Estes SK, Ali RA, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020;12(570):eabd3876. doi:10.1126/scitranslmed.abd3876</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd3876</ArticleId><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Zuo M, Yalavarthi S, et al. Neutrophil extracellular traps and thrombosis in COVID-19. medRxiv. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7642240</ArticleId><ArticleId IdType="pubmed">33151461</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye G, Pan Z, Pan Y, et al. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect. 2020;80(5):14&#x2013;17. doi:10.1016/j.jinf.2020.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.001</ArticleId><ArticleId IdType="pmc">PMC7102560</ArticleId><ArticleId IdType="pubmed">32171867</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigative criteria for suspected cases of SARS-CoV-2 reinfection (ICR). https://www.cdc.gov/coronavirus/2019-ncov/php/invest-criteria.html. Accessed February3, 2021.</Citation></Reference><Reference><Citation>Long QX, Tang XJ, Shi QL, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26(8):1200&#x2013;1204. doi:10.1038/s41591-020-0965-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0965-6</ArticleId><ArticleId IdType="pubmed">32555424</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AW, Shah AS, Johnston JC, Carlsten C, Ryerson CJ. Patient-reported outcome measures after COVID-19: a prospective cohort study. Eur Respir J. 2020;56(5):2003276. doi:10.1183/13993003.03276-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03276-2020</ArticleId><ArticleId IdType="pmc">PMC7530908</ArticleId><ArticleId IdType="pubmed">33008936</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Prabhakar N, Bhalla AS, et al. Computed tomography chest in COVID-19: when &amp; why? Indian J Med Res. 2021;153(1&#x2013;2):86&#x2013;92. doi:10.4103/ijmr.IJMR_3669_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijmr.IJMR_3669_20</ArticleId><ArticleId IdType="pmc">PMC8184074</ArticleId><ArticleId IdType="pubmed">33402610</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Gupta P, Maralakunte M, et al. Diagnostic accuracy of CT and radiographic findings for novel coronavirus 2019 pneumonia: systematic review and meta-analysis. Clin Imaging. 2020;72:75&#x2013;82. doi:10.1016/j.clinimag.2020.11.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinimag.2020.11.021</ArticleId><ArticleId IdType="pmc">PMC7657023</ArticleId><ArticleId IdType="pubmed">33217674</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Dong C, Hu Y, et al. Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study. Radiology. 2020;296(2):E55&#x2013;E64. doi:10.1148/radiol.2020200843</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200843</ArticleId><ArticleId IdType="pmc">PMC7233482</ArticleId><ArticleId IdType="pubmed">32191587</ArticleId></ArticleIdList></Reference><Reference><Citation>Udwadia ZF, Koul PA, Richeldi L. Post-COVID lung fibrosis: the tsunami that will follow the earthquake. Lung India. 2021;38:S41&#x2013;S47. doi:10.4103/lungindia.lungindia_818_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/lungindia.lungindia_818_20</ArticleId><ArticleId IdType="pmc">PMC8104338</ArticleId><ArticleId IdType="pubmed">33686978</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun HJ, Coutavas E, Pine A, et al. Immuno-fibrotic drivers of impaired lung function in post-COVID-19 syndrome. medRxiv [Preprint]. 2021. doi:10.1101/2021.01.31.21250870</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.31.21250870</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X, Jian W, Su Z, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55(6):2001217. doi:10.1183/13993003.01217-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01217-2020</ArticleId><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al.; ARC Study Group. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2020. doi:10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819&#x2013;824. doi:10.1001/jamacardio.2020.1096</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1096</ArticleId><ArticleId IdType="pmc">PMC7364333</ArticleId><ArticleId IdType="pubmed">32219357</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116:1097&#x2013;1100. doi:10.1093/cvr/cvaa078</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa078</ArticleId><ArticleId IdType="pmc">PMC7184507</ArticleId><ArticleId IdType="pubmed">32227090</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417&#x2013;1418. doi:10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420&#x2013;422. doi:10.1016/S2213-2600(20)30076-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Zhao P, Tang D, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13(11):2330&#x2013;2339. doi:10.1016/j.jcmg.2020.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265&#x2013;1273. doi:10.1001/jamacardio.2020.3557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S, Tong MS, Borchers J, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2021;6(1):116&#x2013;118. doi:10.1001/jamacardio.2020.4916</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.4916</ArticleId><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med. 2021;21(1):e63&#x2013;e67. doi:10.7861/clinmed.2020-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon DE, Gallman AE, Hruza GJ, et al. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021;21(3):313&#x2013;314. doi:10.1016/S1473-3099(20)30986-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30986-5</ArticleId><ArticleId IdType="pmc">PMC7836995</ArticleId><ArticleId IdType="pubmed">33460566</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Bunker CB, Ciurtin C, et al. Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy. Lancet Infect Dis. 2021. doi:10.1016/S1473-3099(21)00133-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00133-X</ArticleId><ArticleId IdType="pmc">PMC8221732</ArticleId><ArticleId IdType="pubmed">33705725</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchonwanit P, Leerunyakul K, Kositkuljorn C. Cutaneous manifestations in COVID-19: lessons learned from current evidence. J Am Acad Dermatol. 2020;83:e57&#x2013;e60. doi:10.1016/j.jaad.2020.04.094</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.04.094</ArticleId><ArticleId IdType="pmc">PMC7194618</ArticleId><ArticleId IdType="pubmed">32339706</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683&#x2013;690. doi:10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB, Ptacek R, Ptackova H, Martin A, Kream RM. Selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce &#x2018;Brain Fog&#x2019; and results in behavioral changes that favor viral survival. Med Sci Monit. 2021;27:e930886. doi:10.12659/MSM.930886</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.930886</ArticleId><ArticleId IdType="pmc">PMC7845145</ArticleId><ArticleId IdType="pubmed">33487628</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251&#x2013;2261. doi:10.1007/s00405-020-05965-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, et al. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484. doi:10.1016/j.eclinm.2020.100484</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268&#x2013;2270. doi:10.1056/NEJMc2008597</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611&#x2013;627. doi:10.1016/S2215-0366(20)30203-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker AM, Sricharoenchai T, Raparla S, et al. Posttraumatic stress disorder in critical illness survivors: a metaanalysis. Crit Care Med. 2015;43:1121&#x2013;1129. doi:10.1097/CCM.0000000000000882</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000882</ArticleId><ArticleId IdType="pubmed">25654178</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikayin S, Rabiee A, Hashem MD, et al. Anxiety symptoms in survivors of critical illness: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2016;43:23&#x2013;29. doi:10.1016/j.genhosppsych.2016.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2016.08.005</ArticleId><ArticleId IdType="pmc">PMC5289740</ArticleId><ArticleId IdType="pubmed">27796253</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabiee A, Nikayin S, Hashem MD, et al. Depressive symptoms after critical illness: a systematic review and meta-analysis. Crit Care Med. 2016;44:1744&#x2013;1753. doi:10.1097/CCM.0000000000001811</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001811</ArticleId><ArticleId IdType="pmc">PMC7418220</ArticleId><ArticleId IdType="pubmed">27153046</ArticleId></ArticleIdList></Reference><Reference><Citation>Wohleb ES, Franklin T, Iwata M, Duman RS. Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci. 2016;17:497&#x2013;511. doi:10.1038/nrn.2016.69</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.69</ArticleId><ArticleId IdType="pubmed">27277867</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins RO, Weaver LK, Pope D, et al. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999;160:50&#x2013;56. doi:10.1164/ajrccm.160.1.9708059</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.160.1.9708059</ArticleId><ArticleId IdType="pubmed">10390379</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone A, Mollaioli D, Ciocca G, et al. Addressing male sexual and reproductive health in the wake of COVID-19 outbreak. J Endocrinol Invest. 2021;44(2):223&#x2013;231. doi:10.1007/s40618-020-01350-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01350-1</ArticleId><ArticleId IdType="pmc">PMC7355084</ArticleId><ArticleId IdType="pubmed">32661947</ArticleId></ArticleIdList></Reference><Reference><Citation>Anwar S, Acharya S, Shabih S, Khabut A. Acute limb ischemia in COVID-19 disease: a mysterious coagulopathy. Cureus. 2020;12(7):e9167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7423495</ArticleId><ArticleId IdType="pubmed">32802604</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya S, Anwar S, Siddiqui FS, Shabih S, Manchandani U, Dalezman S. Renal artery thrombosis in COVID-19. IDCases. 2020;22:e00968. doi:10.1016/j.idcr.2020.e00968</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2020.e00968</ArticleId><ArticleId IdType="pmc">PMC7518798</ArticleId><ArticleId IdType="pubmed">33014708</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinho PM, Marcos AAA, Romano AC, Nascimento H, Jr BR. Retinal findings in patients with COVID-19. Lancet. 2020;395(10237):1610. doi:10.1016/S0140-6736(20)31014-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31014-X</ArticleId><ArticleId IdType="pmc">PMC7217650</ArticleId><ArticleId IdType="pubmed">32405105</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez CE, Franz CK, Ko JH, et al. Imaging review of peripheral nerve injuries in patients with COVID-19. Radiology. 2021;298(3):E117&#x2013;E130. doi:10.1148/radiol.2020203116</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020203116</ArticleId><ArticleId IdType="pmc">PMC7709352</ArticleId><ArticleId IdType="pubmed">33258748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323:1239&#x2013;1242. doi:10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojo AS, Balogun SA, Williams OT, Ojo OS. Pulmonary fibrosis in COVID-19 survivors: predictive factors and risk reduction strategies. Pulm Med. 2020;2020:6175964. doi:10.1155/2020/6175964</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6175964</ArticleId><ArticleId IdType="pmc">PMC7439160</ArticleId><ArticleId IdType="pubmed">32850151</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolowska M, Lukasik ZM, Agache I, et al. Immunology of COVID-19: mechanisms, clinical outcome, diagnostics, and perspectives-a report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2020;75:2445&#x2013;2476. doi:10.1111/all.14462</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14462</ArticleId><ArticleId IdType="pmc">PMC7361752</ArticleId><ArticleId IdType="pubmed">32584441</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzikowska U, Ding M, Tan G, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020;75:2829&#x2013;2845. doi:10.1111/all.14429</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14429</ArticleId><ArticleId IdType="pmc">PMC7300910</ArticleId><ArticleId IdType="pubmed">32496587</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X, Cao YY, Lu XX, et al. Eleven faces of coronavirus disease 2019. Allergy. 2020;75:1699&#x2013;1709. doi:10.1111/all.14289</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14289</ArticleId><ArticleId IdType="pmc">PMC7228397</ArticleId><ArticleId IdType="pubmed">32196678</ArticleId></ArticleIdList></Reference><Reference><Citation>Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669&#x2013;677. doi:10.1016/S1473-3099(20)30243-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30243-7</ArticleId><ArticleId IdType="pmc">PMC7158570</ArticleId><ArticleId IdType="pubmed">32240634</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M; the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020;323(20):2052&#x2013;2059. doi:10.1001/jama.2020.6775</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ; CDC COVID-19 Response Team; IVY Network Investigators. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993&#x2013;998. doi:10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsaysky T, et al. Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the covid symptoms study app. medRxiv. 2020.</Citation></Reference><Reference><Citation>Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus disease 2019 case surveillance - United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):759&#x2013;765. doi:10.15585/mmwr.mm6924e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6924e2</ArticleId><ArticleId IdType="pmc">PMC7302472</ArticleId><ArticleId IdType="pubmed">32555134</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao D, Zhou F, Luo L, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol. 2020;7(9):e671&#x2013;e678. doi:10.1016/S2352-3026(20)30217-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30217-9</ArticleId><ArticleId IdType="pmc">PMC7351397</ArticleId><ArticleId IdType="pubmed">32659214</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle DM, Kim-Schulze S, Huang HH, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26(10):1636&#x2013;1643. doi:10.1038/s41591-020-1051-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Spoto S, Agr&#xf2; FE, Sambuco F, et al. High value of mid-regional proadrenomedullin in COVID-19: a marker of widespread endothelial damage, disease severity, and mortality. J Med Virol. 2021;93(5):2820&#x2013;2827. doi:10.1002/jmv.26676</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26676</ArticleId><ArticleId IdType="pmc">PMC7753433</ArticleId><ArticleId IdType="pubmed">33200824</ArticleId></ArticleIdList></Reference><Reference><Citation>Das KM, Lee EY, Singh R, et al. Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging. 2017;27(3):342&#x2013;349. doi:10.4103/ijri.IJRI_469_16</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijri.IJRI_469_16</ArticleId><ArticleId IdType="pmc">PMC5644332</ArticleId><ArticleId IdType="pubmed">29089687</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckler RA, Hubmayr RD. Ventilator-associated lung injury: a search for better therapeutic targets. Eur Respir J. 2007;30:1216&#x2013;1226. doi:10.1183/09031936.00104907</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00104907</ArticleId><ArticleId IdType="pubmed">18055706</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Liu Y, Xu D, et al. Prediction of the development of pulmonary fibrosis using serial thin-section CT and Clinical features in patients discharged after treatment for COVID-19 pneumonia. Korean J Radiol. 2020;21(6):746&#x2013;755. doi:10.3348/kjr.2020.0215</Citation><ArticleIdList><ArticleId IdType="doi">10.3348/kjr.2020.0215</ArticleId><ArticleId IdType="pmc">PMC7231610</ArticleId><ArticleId IdType="pubmed">32410413</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Liu Z, Chen Y, et al. Bacterial and fungal infections in COVID-19 patients: a matter of concern. Infect Control Hosp Epidemiol. 2020;41(9):1124&#x2013;1125. doi:10.1017/ice.2020.156</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2020.156</ArticleId><ArticleId IdType="pmc">PMC7184139</ArticleId><ArticleId IdType="pubmed">32317036</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Barratt SL, Condliffe R, et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75(11):1009&#x2013;1016. doi:10.1136/thoraxjnl-2020-215314</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215314</ArticleId><ArticleId IdType="pubmed">32839287</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8:807&#x2013;815. doi:10.1016/S2213-2600(20)30225-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30225-3</ArticleId><ArticleId IdType="pmc">PMC7228727</ArticleId><ArticleId IdType="pubmed">32422178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed AA, Alawna M. Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (COVID-19): a review. Diabetes Metab Syndr. 2020;14(4):489&#x2013;496. doi:10.1016/j.dsx.2020.04.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.038</ArticleId><ArticleId IdType="pmc">PMC7186129</ArticleId><ArticleId IdType="pubmed">32388326</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>